Mechanisms of Hippo pathway regulation

Genes and Development

Volumn 30, Issue 1, 2016, Pages 1-17

  Meng, Zhipeng ^a   Moroishi, Toshiro ^a   Guan, Kun Liang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

LATS; MAP4K; MST; TAZ; TEAD; YAP

Indexed keywords

CASPASE 3; CASPASE 6; CASPASE 7; G PROTEIN COUPLED RECEPTOR; HIPPO KINASE; LATS PROTEIN; MATS 2 PROTEIN; MST PROTEIN; MST1 PROTEIN; PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TAZ; TRANSCRIPTION FACTOR YAP; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; PROTEIN SERINE THREONINE KINASE;

ACTIN FILAMENT; CELL CONTACT; CELL CYCLE; CELL POLARITY; CELL STRUCTURE; CRYSTAL STRUCTURE; CYTOARCHITECTURE; DIMERIZATION; DROSOPHILA; DROSOPHILA MELANOGASTER; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HIPPO PATHWAY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE GROWTH; UBIQUITINATION; ANIMAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; DROSOPHILA MELANOGASTER; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84953406791     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.274027.115     Document Type: Review

References (201)

1. Aerne BL, Gailite I, Sims D, Tapon N. 2015. Hippo stabilises its adaptor salvador by antagonising the HECT ubiquitin ligase Herc4. PLoS One 10: e0131113.
2. Anastas JN, Moon RT. 2013. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13: 11-26.
3. Antonescu CR, Le Loarer F, Mosquera JM, Sboner A, Zhang L, Chen CL, Chen HW, Pathan N, Krausz T, Dickson BC, et al. 2013. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 52: 775-784.
4. Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, Dupont S, Piccolo S. 2013. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154: 1047-1059.
5. Ardestani A, Paroni F, Azizi Z, Kaur S, Khobragade V, Yuan T, Frogne T, Tao W, Oberholzer J, Pattou F, et al. 2014. MST1 is a key regulator of β cell apoptosis and dysfunction in diabetes. Nat Med 20: 385-397.
6. Artinian N, Cloninger C, Holmes B, Benavides-Serrato A, Bashir T, Gera J. 2015. Phosphorylation of the Hippo pathway component AMOTL2 by the mTORC2 kinase promotes YAP signaling, resulting in enhanced glioblastoma growth and invasiveness. J Biol Chem 290: 19387-19401.
7. Bae SJ, Kim M, Kim SH, Kwon YE, Lee JH, Kim J, Chung CH, Lee WJ, Seol JH. 2015. NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway. Nat Commun 6: 6314.
8. Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S, et al. 2013. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493: 106-110.
9. Bichsel SJ, Tamaskovic R, Stegert MR, Hemmings BA. 2004. Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. J Biol Chem 279: 35228-35235.
10. Boggiano JC, Vanderzalm PJ, Fehon RG. 2011. Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador- Warts tumor suppressor pathway. Dev Cell 21: 888-895.
11. Bothos J, Tuttle RL, Ottey M, Luca FC, Halazonetis TD. 2005. Human LATS1 is a mitotic exit network kinase. Cancer Res 65: 6568-6575.
12. Buvall L, Rashmi P, Lopez-Rivera E, Andreeva S, Weins A, Wallentin H, Greka A, Mundel P. 2013. Proteasomal degradation of Nck1 but not Nck2 regulates RhoA activation and actin dynamics. Nat Commun 4: 2863.
13. Cabochette P, Vega-Lopez G, Bitard J, Parain K, Chemouny R, Masson C, Borday C, Hedderich M, Henningfeld KA, Locker M, et al. 2015. YAP controls retinal stem cellDNAreplication timing and genomic stability. Elife 4: e08488.
14. Cai J, Zhang N, Zheng Y, deWilde RF, Maitra A, Pan D. 2010. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24: 2383-2388.
15. Callus BA, Verhagen AM, Vaux DL. 2006. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J 273: 4264-4276.
16. Camargo FD, Gokhale S, Johnnidis JB, Fu D, BellGW, Jaenisch R, Brummelkamp TR. 2007. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17: 2054-2060.
17. Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA, Sillje HH. 2005. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24: 2076-2086.
18. Chen Q, Zhang N, Gray RS, Li H, Ewald AJ, Zahnow CA, Pan D. 2014. A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis. Genes Dev 28: 432-437.
19. Chen HY, Yu SL, Ho BC, Su KY, Hsu YC, Chang CS, Li YC, Yang SY, Hsu PY, Ho H, et al. 2015a. R331W missense mutation of oncogeneYAP1 is a germline risk allele for lung adenocarcinoma with medical actionability. J Clin Oncol 33: 2303-2310.
20. Chen Q, Zhang N, Xie R, Wang W, Cai J, Choi KS, David KK, Huang B, Yabuta N, Nojima H, et al. 2015b. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev 29: 1285-1297.
21. Cheung WL, Ajiro K, Samejima K, Kloc M, Cheung P, MizzenCA, Beeser A, Etkin LD, Chernoff J, Earnshaw WC, et al. 2003. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113: 507-517.
22. Codelia VA, Sun G, Irvine KD. 2014. Regulation of YAP by mechanical strain through Jnk and Hippo signaling. Curr Biol 24: 2012-2017.
23. Collak FK, Yagiz K, Luthringer DJ, Erkaya B, Cinar B. 2012. Threonine- 120 phosphorylation regulated by phosphoinositide-3- kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20- like kinase 1. J Biol Chem 287: 23698-23709.
24. Couzens AL, Knight JD, Kean MJ, Teo G,Weiss A, Dunham WH, Lin ZY, Bagshaw RD, Sicheri F, Pawson T, et al. 2013. Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci Signal 6: rs15.
25. Dan I, Watanabe NM, Kusumi A. 2001. The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol 11: 220-230.
26. Deng H, Wang W, Yu J, Zheng Y, Qing Y, Pan D. 2015. Spectrin regulates Hippo signaling by modulating cortical actomyosin activity. Elife 4: e06567.
27. Dent LG, Poon CL, Zhang X, Degoutin JL, Tipping M, Veraksa A, Harvey KF. 2015. The GTPase regulatory proteins Pix and Git control tissue growth via the Hippo pathway. Curr Biol 25: 124-130.
28. DeRan M, Yang J, Shen CH, Peters EC, Fitamant J, Chan P, Hsieh M, Zhu S, Asara JM, Zheng B, et al. 2014. Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep 9: 495-503.
29. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D. 2007. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133.
30. Driscoll TP, Cosgrove BD, Heo SJ, Shurden ZE, Mauck RL. 2015. Cytoskeletal to nuclear strain transfer regulates YAP signaling in mesenchymal stem cells. Biophys J 108: 2783-2793.
31. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, et al. 2011. Role of YAP/TAZ in mechanotransduction. Nature 474: 179-183.
32. Eferl R, Wagner EF. 2003. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868.
33. Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, Zaidi MR, Ksander BR, Merlino G, Sodhi A, et al. 2014. Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell 25: 831-845.
34. Fletcher GC, Elbediwy A, Khanal I, Ribeiro PS, Tapon N, Thompson BJ. 2015. The Spectrin cytoskeleton regulates the Hippo signalling pathway. EMBO J 34: 940-954.
35. Gailite I, Aerne BL, Tapon N. 2015. Differential control of Yorkie activity by LKB1/AMPK and the Hippo/Warts cascade in the central nervous system. Proc Natl Acad Sci 112: E5169- E5178.
36. Galli GG, Carrara M, Yuan WC, Valdes-Quezada C, Gurung B, Pepe-Mooney B, Zhang T, Geeven G, Gray NS, de Laat W, et al. 2015. YAP drives growth by controlling transcriptional pause release from dynamic enhancers. Mol Cell 60: 328-337.
37. Ganem NJ, Cornils H, Chiu SY, O'Rourke KP, Arnaud J, Yimlamai D, Thery M, Camargo FD, Pellman D. 2014. Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell 158: 833-848.
38. Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. 2010. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 18: 300-308.
39. Geng J, Sun X,Wang P, Zhang S,Wang X, WuH, Hong L, Xie C, Li X, Zhao H, et al. 2015. Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. Nat Immunol 16: 1142-1152.
40. Ger M, Zitkus Z, Valius M. 2011. Adaptor protein Nck1 interacts with p120 Ras GTPase-activating protein and regulates its activity. Cell Signal 23: 1651-1658.
41. Glantschnig H, Rodan GA, Reszka AA. 2002. Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation. J Biol Chem 277: 42987-42996.
42. Gogl G, Schneider KD, Yeh BJ, Alam N, Nguyen Ba AN, Moses AM, Hetenyi C, Remenyi A, Weiss EL. 2015. The structure of an NDR/LATS kinase-Mob complex reveals a novel kinase- coactivator system and substrate docking mechanism. PLoS Biol 13: e1002146.
43. Gong R, Hong AW, Plouffe SW, Zhao B, Liu G, Yu FX, Xu Y, Guan KL. 2015. Opposing roles of conventional and novel PKC isoforms in Hippo-YAP pathway regulation. Cell Res 25: 985-988.
44. Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J, Zider A. 2008. SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol 18: 435-441.
45. Gregorieff A, Liu Y, Inanlou MR, Khomchuk Y, Wrana JL. 2015. Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer. Nature 526: 715-718.
46. Gumbiner BM, Kim NG. 2014. The Hippo-YAP signaling pathway and contact inhibition of growth. J Cell Sci 127: 709-717.
47. Guo C, Tommasi S, Liu L, Yee JK, Dammann R, Pfeifer GP. 2007. RASSF1A is part of a complex similar to the Drosophila Hippo/ Salvador/Lats tumor-suppressor network. Curr Biol 17: 700-705.
48. Guo C, Zhang X, Pfeifer GP. 2011. The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2. J Biol Chem 286: 6253-6261.
49. Hansen CG, Moroishi T, Guan KL. 2015. YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol 25: 499-513.
50. Harvey K, Tapon N. 2007. The Salvador-Warts-Hippo pathway- an emerging tumour-suppressor network. Nat Rev Cancer 7: 182-191.
51. Harvey KF, Pfleger CM, Hariharan IK. 2003. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114: 457-467.
52. Heidary Arash E, Song KM, Song S, Shiban A, Attisano L. 2014. Arhgef7 promotes activation of the Hippo pathway core kinase Lats. EMBO J 33: 2997-3011.
53. Hergovich A, Bichsel SJ, Hemmings BA. 2005. Human NDR kinases are rapidly activated by MOB proteins through recruitment to the plasma membrane and phosphorylation. Mol Cell Biol 25: 8259-8272.
54. Hergovich A, Schmitz D, Hemmings BA. 2006. The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem Biophys Res Commun 345: 50-58.
55. Hergovich A, Kohler RS, Schmitz D, Vichalkovski A, Cornils H, Hemmings BA. 2009. The MST1 and hMOB1 tumor suppressors control human centrosome duplication by regulating NDR kinase phosphorylation. Curr Biol 19: 1692-1702.
56. HirotaT, MorisakiT, NishiyamaY, MarumotoT, Tada K, Hara T, Masuko N, Inagaki M, Hatakeyama K, Saya H. 2000. Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J Cell Biol 149: 1073-1086.
57. Ho KC, Zhou Z, She YM, Chun A, Cyr TD, Yang X. 2011. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected]. Proc Natl Acad Sci 108: 4870-4875.
58. Hu Y, Leo C, Yu S, Huang BC, Wang H, Shen M, Luo Y, Daniel- Issakani S, Payan DG, Xu X. 2004. Identification and functional characterization of a novel human misshapen/Nck interacting kinase-related kinase, hMINKβ. J Biol Chem 279: 54387-54397.
59. Huang J,WuS, Barrera J, Matthews K, Pan D. 2005. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 122: 421-434.
60. Ikmi A, Gaertner B, Seidel C, Srivastava M, Zeitlinger J, Gibson MC. 2014. Molecular evolution of the Yap/Yorkie proto-oncogene and elucidation of its core transcriptional program. Mol Biol Evol 31: 1375-1390.
61. Imajo M, Ebisuya M, Nishida E. 2015. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Nat Cell Biol 17: 7-19.
62. Jang SW, Yang SJ, Srinivasan S, Ye K. 2007. Akt phosphorylates MstI and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation. J Biol Chem 282: 30836-30844.
63. Jia J, Zhang W, Wang B, Trinko R, Jiang J. 2003. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev 17: 2514-2519.
64. Jiao S, Wang H, Shi Z, Dong A, Zhang W, Song X, He F, Wang Y, Zhang Z, Wang W, et al. 2014. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell 25: 166-180.
65. Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. 1995. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 9: 534-546.
66. Kango-Singh M, Nolo R, Tao C, Verstreken P, Hiesinger PR, Bellen HJ, Halder G. 2002. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 129: 5719-5730.
67. Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, Zhang XF, Seed B, Avruch J. 2002. Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 12: 253-265.
68. Kim NG, Gumbiner BM. 2015. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway. J Cell Biol 210: 503-515.
69. Kim NG, Koh E, Chen X, Gumbiner BM. 2011. E-cadherin mediates contact inhibition of proliferation through Hippo signaling- pathway components. Proc Natl Acad Sci 108: 11930-11935.
70. Kim M, Kim M, Lee S, Kuninaka S, Saya H, Lee H, Lee S, Lim DS. 2013. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. EMBO J 32: 1543-1555.
71. Kim KM, Choi YJ, Hwang JH, Kim AR, Cho HJ, Hwang ES, Park JY, Lee SH, Hong JH. 2014. Shear stress induced by an interstitial level of slow flow increases the osteogenic differentiation of mesenchymal stem cells through TAZ activation. PLoS One 9: e92427.
72. Kim M, Kim T, Johnson RL, Lim DS. 2015. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Cell Rep 11: 270-282.
73. Kohler RS, Schmitz D, Cornils H, Hemmings BA, Hergovich A. 2010. Differential NDR/LATS interactions with the human MOBfamily reveal a negative role for humanMOB2in the regulation of human NDR kinases. Mol Cell Biol 30: 4507-4520.
74. Koontz LM, Liu-Chittenden Y, Yin F, Zheng Y, Yu J, Huang B, Chen Q, Wu S, Pan D. 2013. The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev Cell 25: 388-401.
75. Kwon Y, Vinayagam A, Sun X, Dephoure N, Gygi SP, Hong P, Perrimon N. 2013. The Hippo signaling pathway interactome. Science 342: 737-740.
76. Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N, Ho LL, Li Y. 2005. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120: 675-685.
77. Lappano R, Maggiolini M. 2011. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 10: 47-60.
78. Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS, Kim MC, Jeong WI, Calvisi DF, Kim JM, et al. 2010. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci 107: 8248-8253.
79. Lee MJ, Ran Byun M, Furutani-Seiki M, Hong JH, Jung HS. 2014. YAP and TAZ regulate skin wound healing. J Invest Dermatol 134: 518-525.
80. Lehtinen MK, Yuan Z, Boag PR, Yang Y, Villen J, Becker EB, DiBacco S, de la Iglesia N, Gygi S, Blackwell TK, et al. 2006. A conserved MST-FOXO signaling pathway mediates oxidative- stress responses and extends life span. Cell 125: 987- 1001.
81. Li Q, Li S, Mana-Capelli S, Roth Flach RJ, Danai LV, Amcheslavsky A, Nie Y, Kaneko S, Yao X, Chen X, et al. 2014a. The conserved Misshapen-Warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila. Dev Cell 31: 291-304.
82. LiW, Cooper J, Zhou L, Yang C, Erdjument-Bromage H, Zagzag D, Snuderl M, Ladanyi M, Hanemann CO, Zhou P, et al. 2014b. Merlin/NF2 loss-driven tumorigenesis linked to CRL4 (DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. Cancer Cell 26: 48-60.
83. Li Y, Zhou H, Li F, ChanSW, Lin Z, Wei Z, Yang Z, Guo F, Lim CJ, XingW, et al. 2015. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway. Cell Res 25: 801-817.
84. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LS, Abujarour R, et al. 2010. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 24: 1106-1118.
85. Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, Gallazzini M, Olson EN, Lam H, Henske EP, et al. 2014. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med 211: 2249-2263.
86. Lignitto L, Arcella A, Sepe M, Rinaldi L, Delle Donne R, Gallo A, Stefan E, Bachmann VA, Oliva MA, Tiziana Storlazzi C, et al. 2013. Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth. Nat Commun 4: 1822.
87. Ling P, Yao Z, Meyer CF,Wang XS, OehrlW, Feller SM, Tan TH. 1999. Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase. Mol Cell Biol 19: 1359-1368.
88. Ling P, Meyer CF, Redmond LP, Shui JW, Davis B, Rich RR, Hu MC,Wange RL, Tan TH. 2001. Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling. J Biol Chem 276: 18908-18914.
89. Liu CY, Zha ZY, Zhou X, Zhang H, HuangW, Zhao D, Li T, Chan SW, Lim CJ, Hong W, et al. 2010. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFβ-TrCP E3 ligase. J Biol Chem 285: 37159-37169.
90. Liu G, Yu FX, Kim YC, Meng Z, Naipauer J, Looney DJ, Liu X, Gutkind JS, Mesri EA, Guan KL. 2015. Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Oncogene 34: 3536-3546.
91. Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, Liu JO, Pan D. 2012. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 26: 1300-1305.
92. Lu L, Li Y, Kim SM, BossuytW, Liu P, Qiu Q, Wang Y, Halder G, Finegold MJ, Lee JS, et al. 2010. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci 107: 1437-1442.
93. Lv XB, Liu CY,Wang Z, Sun YP, Xiong Y, Lei QY, Guan KL. 2015. PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction. EMBO Rep 16: 975-985.
94. Ma B, Chen Y, Chen L, Cheng H, Mu C, Li J, Gao R, Zhou C, Cao L, Liu J, et al. 2015. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat Cell Biol 17: 95-103.
95. Maejima Y, Kyoi S, Zhai P, Liu T, Li H, Ivessa A, Sciarretta S, Del Re DP, Zablocki DK, Hsu CP, et al. 2013. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med 19: 1478-1488.
96. Mamada H, Sato T, Ota M, Sasaki H. 2015. Cell competition in mouse NIH3T3 embryonic fibroblasts is controlled by the activity of Tead family proteins and Myc. J Cell Sci 128: 790-803.
97. Meng Z, Moroishi T, Mottier-Pavie V, Plouffe SW, Hansen CG, Hong AW, Park HW, Mo JS, Lu W, Lu S, et al. 2015. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/ 2 in the Hippo pathway. Nat Commun 6: 8357.
98. Miller E, Yang J, DeRan M, Wu C, Su AI, Bonamy GM, Liu J, Peters EC, Wu X. 2012. Identification of serum-derived sphingosine- 1-phosphate as a small molecule regulator of YAP. Chem Biol 19: 955-962.
99. Mo JS, Yu FX, Gong R, Brown JH, Guan KL. 2012. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev 26: 2138-2143.
100. Mo JS, Meng Z, Kim YC, Park HW, Hansen CG, Kim S, Lim DS, Guan KL. 2015. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol 17: 500-510.
101. Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed J, Alb JG, Magnuson TR, O'Neal W, Milgram SL. 2006. Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol Cell Biol 26: 77-87.
102. Morisaki T, Hirota T, Iida S, Marumoto T, Hara T, Nishiyama Y, Kawasuzi M, Hiraoka T, Mimori T, Araki N, et al. 2002. WARTS tumor suppressor is phosphorylated by Cdc2/cyclin B at spindle poles during mitosis. FEBS Lett 529: 319-324.
103. Moroishi T, Hansen CG, Guan KL. 2015a. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer 15: 73-79.
104. Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan D, et al. 2015b. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev 29: 1271-1284.
105. Ni L, Li S, Yu J, Min J, Brautigam CA, Tomchick DR, Pan D, Luo X. 2013. Structural basis for autoactivation of human Mst2 kinase and its regulation by RASSF5. Structure 21: 1757-1768.
106. Ni L, Zheng Y, Hara M, Pan D, Luo X. 2015. Structural basis for Mob1-dependent activation of the core Mst-Lats kinase cascade in Hippo signaling. Genes Dev 29: 1416-1431.
107. Nishikimi A, Ishihara S, Ozawa M, Etoh K, Fukuda M, Kinashi T, Katagiri K. 2014. Rab13 acts downstream of the kinase Mst1 to deliver the integrin LFA-1 to the cell surface for lymphocyte trafficking. Sci Signal 7: ra72.
108. Nishio M, Hamada K, Kawahara K, Sasaki M, Noguchi F, Chiba S, Mizuno K, Suzuki SO, Dong Y, Tokuda M, et al. 2012. Cancer susceptibility and embryonic lethality in Mob1a/1b doublemutant mice. J Clin Invest 122: 4505-4518.
109. Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A, Yabuta N, Hirahara S, Stephenson RO, Ogonuki N, et al. 2009. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell 16: 398-410.
110. Oh H, Slattery M, Ma L, Crofts A, White KP, Mann RS, Irvine KD. 2013. Genome-wide association of Yorkie with chromatin and chromatin-remodeling complexes. Cell Rep 3: 309-318.
111. Oh H, Slattery M, Ma L, White KP, Mann RS, Irvine KD. 2014. Yorkie promotes transcription by recruiting a histone methyltransferase complex. Cell Rep 8: 449-459.
112. Ota M, Sasaki H. 2008. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135: 4059-4069.
113. Pantalacci S, Tapon N, Leopold P. 2003. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol 5: 921-927.
114. ParkHW, Kim YC, Yu B, Moroishi T, Mo JS, Plouffe SW, Meng Z, Lin KC, Yu FX, Alexander CM, et al. 2015. Alternative Wnt signaling activates YAP/TAZ. Cell 162: 780-794.
115. Parker J, Struhl G. 2015. Scaling the Drosophila wing: TOR-dependent target gene access by the Hippo pathway transducer Yorkie. PLoS Biol 13: e1002274.
116. Patel NR, Salim AA, Sayeed H, Sarabia SF, Hollingsworth F,Warren M, Jakacky J, Tanas M, Oliveira AM, Rubin BP, et al. 2015. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants. Histopathology 67: 699-708.
117. Pearce LR, Komander D, Alessi DR. 2010. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol 11: 9-22.
118. Pefani DE, Latusek R, Pires I, Grawenda AM, Yee KS, Hamilton G, van der Weyden L, Esashi F, Hammond EM, O'Neill E. 2014. RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2. Nat Cell Biol 16: 962-971.
119. Piccolo S, Dupont S, Cordenonsi M. 2014. The biology of YAP/ TAZ: hippo signaling and beyond. Physiol Rev 94: 1287-1312.
120. Plouffe SW, Hong AW, Guan KL. 2015. Disease implications of the Hippo/YAP pathway. Trends Mol Med 21: 212-222.
121. Poon CL, Lin JI, Zhang X, Harvey KF. 2011. The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador- Warts-Hippo pathway. Dev Cell 21: 896-906.
122. Praskova M, Khoklatchev A, Ortiz-Vega S, Avruch J. 2004. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem J 381: 453-462.
123. Praskova M, Xia F, Avruch J. 2008. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol 18: 311-321.
124. Qing Y, Yin F,WangW, Zheng Y, Guo P, Schozer F, Deng H, Pan D. 2014. The Hippo effector Yorkie activates transcription by interacting with a histone methyltransferase complex through Ncoa6. Elife 3: e02564.
125. Rauskolb C, Sun S, Sun G, Pan Y, Irvine KD. 2014. Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex. Cell 158: 143-156.
126. Rawat SJ, Creasy CL, Peterson JR, Chernoff J. 2013. The tumor suppressor Mst1 promotes changes in the cellular redox state by phosphorylation and inactivation of peroxiredoxin-1 protein. J Biol Chem 288: 8762-8771.
127. Rodrigues-Campos M, Thompson BJ. 2014. The ubiquitin ligase FbxL7 regulates the Dachsous-Fat-Dachs system in Drosophila. Development 141: 4098-4103.
128. Ruusala A, Pawson T, Heldin CH, Aspenstrom P. 2008. Nck adapters are involved in the formation of dorsal ruffles, cell migration, and Rho signaling downstream of the platelet-derived growth factor β receptor. J Biol Chem 283: 30034-30044.
129. Sabine A, Bovay E, Demir CS, Kimura W, Jaquet M, Agalarov Y, Zangger N, Scallan JP, Graber W, Gulpinar E, et al. 2015. FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature. J Clin Invest 125: 3861-3877.
130. Salah Z, Melino G, Aqeilan RI. 2011. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. Cancer Res 71: 2010-2020.
131. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR, et al. 2011. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 144: 782-795.
132. Schroeder MC, Halder G. 2012. Regulation of the Hippo pathway by cell architecture and mechanical signals. Semin Cell Dev Biol 23: 803-811.
133. Sciarretta S, Zhai P, Maejima Y, Del Re DP, Nagarajan N, Yee D, Liu T, Magnuson MA, Volpe M, Frati G, et al. 2015. mTORC2 regulates cardiac response to stress by inhibiting MST1. Cell Rep 11: 125-136.
134. Shao D, Zhai P, Del ReDP, Sciarretta S, Yabuta N, Nojima H, Lim DS, Pan D, Sadoshima J. 2014. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun 5: 3315.
135. Shen S, Guo X, Yan H, Lu Y, Ji X, Li L, Liang T, Zhou D, Feng XH, Zhao JC, et al. 2015. A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis. Cell Res 25: 997- 1012.
136. Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD, Lantz DM, Seykora JT, Vasioukhin V. 2011. α- Catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal 4: ra33.
137. Skibinski A, Breindel JL, Prat A, Galvan P, Smith E, Rolfs A, Gupta PB, Labaer J, Kuperwasser C. 2014. The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment. Cell Rep 6: 1059-1072.
138. Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, Chen Y, Park O, Chang J, Simpson RM, et al. 2010.Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci 107: 1431-1436.
139. Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio R, Piazza S, et al. 2014. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat Cell Biol 16: 357-366.
140. Stegert MR, Tamaskovic R, Bichsel SJ, Hergovich A, Hemmings BA. 2004. Regulation of NDR2 protein kinase by multi-site phosphorylation and the S100B calcium-binding protein. J Biol Chem 279: 23806-23812.
141. Stegert MR, Hergovich A, Tamaskovic R, Bichsel SJ, Hemmings BA. 2005. Regulation of NDR protein kinase by hydrophobic motif phosphorylation mediated by the mammalian Ste20- like kinase MST3. Mol Cell Biol 25: 11019-11029.
142. Stein C, Bardet AF, Roma G, Bergling S, Clay I, Ruchti A, Agarinis C, Schmelzle T, Bouwmeester T, Schubeler D, et al. 2015. YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers. PLoS Genet 11: e1005465.
143. Su YC, Han J, Xu S, Cobb M, Skolnik EY. 1997. NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain. EMBO J 16: 1279-1290.
144. Sun G, Irvine KD. 2013. Ajuba family proteins link JNK to Hippo signaling. Sci Signal 6: ra81.
145. Sun Y, Yong KM, Villa-Diaz LG, Zhang X, Chen W, Philson R, Weng S, Xu H, Krebsbach PH, Fu J. 2014. Hippo/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells. Nat Mater 13: 599-604.
146. Sun S, Reddy BV, Irvine KD. 2015. Localization of Hippo signalling complexes and Warts activation in vivo. Nat Commun 6: 8402.
147. Szymaniak AD, Mahoney JE, Cardoso WV, Varelas X. 2015. Crumbs3-mediated polarity directs airway epithelial cell fate through the Hippo pathway effector Yap. Dev Cell 34: 283-296.
148. Tamaskovic R, Bichsel SJ, Rogniaux H, Stegert MR, Hemmings BA. 2003. Mechanism of Ca2+-mediated regulation of NDR protein kinase through autophosphorylation and phosphorylation by an upstream kinase. J Biol Chem 278: 6710-6718.
149. Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, Flanagan J, Luo Y, Fenwick K, Natrajan R, et al. 2011. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med 3: 98ra82.
150. Tang F, Gill J, Ficht X, Barthlott T,Cornils H, Schmitz-Rohmer D, Hynx D, Zhou D, Zhang L, Xue G, et al. 2015. The kinases NDR1/2 act downstream of the Hippo homolog MST1 to mediate both egress of thymocytes from the thymus and lymphocyte motility. Sci Signal 8: ra100.
151. Taniguchi K, Wu LW, Grivennikov SI, de Jong PR, Lian I, Yu FX, Wang K, Ho SB, Boland BS, Chang JT, et al. 2015.Agp130-Src- YAP module links inflammation to epithelial regeneration. Nature 519: 57-62.
152. TaoW, Zhang S, Turenchalk GS, Stewart RA, St John MA, Chen W, Xu T. 1999. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet 21: 177-181.
153. Tapon N, Harvey KF, BellDW, Wahrer DC, Schiripo TA, Haber D, Hariharan IK. 2002. salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110: 467-478.
154. Taylor LK, Wang HC, Erikson RL. 1996. Newly identified stressresponsive protein kinases, Krs-1 and Krs-2. Proc Natl Acad Sci 93: 10099-10104.
155. Toji S, Yabuta N, Hosomi T, Nishihara S, Kobayashi T, Suzuki S, Tamai K, Nojima H. 2004. The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase. Genes Cells 9: 383-397.
156. Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G. 2003. Hippo promotes proliferation arrest and apoptosis in the Salvador/ Warts pathway. Nat Cell Biol 5: 914-920.
157. Valencia-Sama I, Zhao Y, Lai D, Janse van Rensburg HJ, Hao Y, Yang X. 2015. Hippo component TAZfunctions as a co-repressor and negatively regulates ΔNp63 transcription through TEA domain (TEAD) transcription factor. J Biol Chem 290: 16906-16917.
158. Vichalkovski A, Gresko E, Cornils H, Hergovich A, Schmitz D, Hemmings BA. 2008. NDR kinase is activated by RASSF1A/ MST1 in response to Fas receptor stimulation and promotes apoptosis. Curr Biol 18: 1889-1895.
159. Wang C, An J, Zhang P, Xu C, Gao K, Wu D, Wang D, Yu H, Liu JO, Yu L. 2012. The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation. Biochem J 444: 279-289.
160. WangW, Li X, Huang J, Feng L, Dolinta KG, Chen J. 2014. Defining the protein-protein interaction network of the human hippo pathway. Mol Cell Proteomics 13: 119-131.
161. Wang W, Xiao ZD, Li X, Aziz KE, Gan B, Johnson RL, Chen J. 2015. AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol 17: 490-499.
162. Wehr MC, Holder MV, Gailite I, Saunders RE, Maile TM, Ciirdaeva E, Instrell R, Jiang M, Howell M, Rossner MJ, et al. 2013. Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila. Nat Cell Biol 15: 61-71.
163. Wei X, Shimizu T, Lai ZC. 2007. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J 26: 1772-1781.
164. Wilkinson DS, Jariwala JS, Anderson E, Mitra K, Meisenhelder J, Chang JT, Ideker T, Hunter T, Nizet V, Dillin A, et al. 2015. Phosphorylation of LC3 by the Hippo kinases STK3/STK4 is essential for autophagy. Mol Cell 57: 55-68.
165. Wong KK, LiW, An Y, Duan Y, Li Z, Kang Y, Yan Y. 2015. β-Spectrin regulates the hippo signaling pathway and modulates the basal actin network. J Biol Chem 290: 6397-6407.
166. WuS, Huang J, Dong J, Pan D. 2003. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114: 445-456.
167. Wu S, Liu Y, Zheng Y, Dong J, Pan D. 2008. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell 14: 388-398.
168. Wu H,Wei L, Fan F, Ji S, Zhang S, Geng J, Hong L, Fan X, Chen Q, Tian J, et al. 2015. Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis. Nat Commun 6: 6239.
169. Xu T,WangW, Zhang S, Stewart RA, YuW. 1995. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121: 1053- 1063.
170. Yabuta N, Okada N, Ito A, Hosomi T, Nishihara S, Sasayama Y, Fujimori A, Okuzaki D, Zhao H, Ikawa M, et al. 2007. Lats2 is an essential mitotic regulator required for the coordination of cell division. J Biol Chem 282: 19259-19271.
171. Yabuta N, Mukai S, Okada N, Aylon Y, Nojima H. 2011. The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis. Cell Cycle 10: 2724-2736.
172. Yang S, Zhang L, Liu M, Chong R, Ding SJ, Chen Y, Dong J. 2013. CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation. Cancer Res 73: 6722-6733.
173. Yang CC, Graves HK, Moya IM, Tao C, Hamaratoglu F, Gladden AB, Halder G. 2015a. Differential regulation of the Hippo pathway by adherens junctions and apical-basal cell polarity modules. Proc Natl Acad Sci 112: 1785-1790.
174. Yang S, Zhang L, Chen X, Chen Y, Dong J. 2015b. Oncoprotein YAP regulates the spindle checkpoint activation in a mitotic phosphorylation-dependent manner through up-regulation of BubR1. J Biol Chem 290: 6191-6202.
175. Yang S, Zhang L, Purohit V, Shukla SK, Chen X, Yu F, Fu K, Chen Y, Solheim J, Singh PK, et al. 2015c. Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3. Oncotarget 6: 36019-36031.
176. Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe- Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ, Camargo FD. 2014. Hippo pathway activity influences liver cell fate. Cell 157: 1324-1338.
177. Yimlamai D, Fowl BH, Camargo FD. 2015. Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer. J Hepatol 63: 1491-1501.
178. Yin F, Yu J, Zheng Y, Chen Q, Zhang N, Pan D. 2013. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 154: 1342- 1355.
179. Yu FX, Guan KL. 2013. The Hippo pathway: regulators and regulations. Genes Dev 27: 355-371.
180. Yu J, Zheng Y, Dong J, Klusza S, Deng WM, Pan D. 2010. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 18: 288-299.
181. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I,Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, et al. 2012. Regulation of the Hippo- YAP pathway by G-protein-coupled receptor signaling. Cell 150: 780-791.
182. Yu FX, Zhang Y, ParkHW, Jewell JL, Chen Q, Deng Y, Pan D, Taylor SS, Lai ZC, Guan KL. 2013. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev 27: 1223-1232.
183. Yu FX, Luo J, Mo JS, Liu G, Kim YC, Meng Z, Zhao L, Peyman G, Ouyang H, Jiang W, et al. 2014. Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell 25: 822-830.
184. Yu FX, Meng Z, Plouffe SW, Guan KL. 2015. Hippo pathway regulation of gastrointestinal tissues. Annu Rev Physiol 77: 201-227.
185. Yuan Z, Kim D, Shu S, Wu J, Guo J, Xiao L, Kaneko S, Coppola D, Cheng JQ. 2010. Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120. J Biol Chem 285: 3815-3824.
186. Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B, Rosato A, Bicciato S, Cordenonsi M, Piccolo S. 2015. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol 17: 1218-1227.
187. Zhang L, Ren F, Zhang Q, Chen Y, Wang B, Jiang J. 2008. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell 14: 377-387.
188. Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J, Giovannini M, Liu P, Anders RA, Pan D. 2010. The Merlin/NF2 tumor suppressor functions through theYAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 19: 27-38.
189. Zhang L, Iyer J, Chowdhury A, Ji M, Xiao L, Yang S, Chen Y, Tsai MY, Dong J. 2012. KIBRA regulates aurora kinase activity and is required for precise chromosome alignment during mitosis. J Biol Chem 287: 34069-34077.
190. Zhang L, Tang F, Terracciano L, Hynx D, Kohler R, Bichet S, Hess D, Cron P, Hemmings BA, Hergovich A, et al. 2015. NDR functions as a physiological YAP1 kinase in the intestinal epithelium. Curr Biol 25: 296-305.
191. Zhao Y, Yang X. 2015. Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling. Oncotarget 6: 21906-21917.
192. Zhao B,Wei X, LiW, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, et al. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761.
193. Zhao B, Ye X, Yu J, Li L, LiW, Li S, Yu J, Lin JD,Wang CY, Chinnaiyan AM, et al. 2008. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971.
194. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. 2010. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(β-TRCP). Genes Dev 24: 72-85.
195. Zhao B, Li L,Wang L, WangCY, Yu J, Guan KL. 2012. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 26: 54-68.
196. Zhao Y, Khanal P, Savage P, She YM, Cyr TD, Yang X. 2014. YAPinduced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway. Cancer Res 74: 4493-4503.
197. Zheng Y, Wang W, Liu B, Deng H, Uster E, Pan D. 2015. Identification of Happyhour/MAP4K as alternative Hpo/Mst-like kinases in the Hippo kinase cascade. Dev Cell 34: 642-655.
198. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, Lauwers GY, ThaslerW, Lee JT, Avruch J, et al. 2009. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16: 425-438.
199. Zhou X,Wang S,Wang Z, Feng X, Liu P, Lv XB, Li F, Yu FX, Sun Y, Yuan H, et al. 2015a. Estrogen regulates Hippo signaling via GPER in breast cancer. J Clin Invest 125: 2123-2135.
200. Zhou Z, Hu T, Xu Z, Lin Z, Zhang Z, Feng T, Zhu L, Rong Y, Shen H, Luk JM, et al. 2015b. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides. FASEB J 29: 724-732.
201. Zhu C, Li L, Zhao B. 2015. The regulation and function of YAP transcription co-activator. Acta Biochim Biophys Sin (Shanghai) 47: 16-28.